Prostatic Neoplasms trials recruiting in New York

All Prostatic Neoplasms trials nationally

Cities in New York

Recruiting trials in New York

• A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
  NCT06925737 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Male · New York: New York, Williamsville
• A Study of JNJ-78278343 in Combination With JNJ-95298177 for Treatment of Prostate Cancer
  NCT07082920 · Phase: Phase 1 · Ages: 18 Years and older · Sex: Male · New York: New York
• A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer
  NCT06095089 · Phase: Phase 1 · Ages: 18 Years and older · Sex: Male · New York: New York
• A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
  NCT06136650 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · New York: Syracuse
• A Study of Pasritamig (JNJ-78278343) in Combination With JNJ-86974680 for Treatment of Prostate Cancer
  NCT07319871 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · New York: New York
• Anti-tumour Activity of (177Lu) rhPSMA-10.1 Injection
  NCT05413850 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: Male · New York: New York
• Diagnostic Utility of rhPSMA-7.3 (18F) PET/CT in Men With Prostate Cancer on Active Surveillance
  NCT07285057 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · New York: New York
• Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
  NCT06056830 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Male · New York: New York